PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen.

Similar documents
PACT premier,* HT-96 MD1-36. PACT premier is a ph, Anion, Cation crystallization trial devised to test ph within a PEG/Ion screen environment.

moleculardimensions.com

The Stura Footprint Combination HT-96 MD1-43 Rapidly analyse the crystallization potential of your protein and protein complexes.

MD1-38 is presented as a 96 x 10 ml condition targeted sparse matrix screen.

MemGold TM. MD1-39 is presented as 96 x 10 ml conditions.

MultiXtal Formulation

Structure Screen 1 & 2 HT-96 Eco Screen

MD1-64-GREEN is a targeted sparse matrix presented as a 96 x 1 ml deep-well block.

Typical ph conditions used for membrane protein crystallization. Total concentration of salts used for membrane protein crystallization.

MD1-74-ECO. MemGold Eco Screen Combo Value Pack (MD1-39-ECO & MD1-63-ECO)

Membrane Proteins. MemGoldMeso 10 ml and HT-96* MD1-114, MD1-115

Clear Strategy TM Screen I HT-96 A 6 4 matrix screen 1 that offers a more rational, logical and flexible approach to crystallization experiments.

MD1-05. The Stura Footprint Combination (MD1-20 & MD1-22)

MD1-32 is presented as 96 x 1 ml conditions in a deep-well block.

MemMeso TM MD1-86. MemMeso TM A 96-condition crystallization screen specifically for use with mesophases. (LCP compatible). Features of MemMeso:

MIDASplus MD MD1-106 is presented as 96 x 10 ml conditions.

MD1-60 is presented as 96 x 1 ml conditions in a deep-well block.

The original systematic screen for membrane proteins.

The PGA Screen TM HT-96. The kit contains 96 1ml conditions in a deep-well block.

CryoProtX MD1 61. MD1-61 is presented as a 46 x 1.5 ml kit. To be used in conjunction with the Quick-Start Guide. Features of CryoProtX :

CryoProtX TM Eco Screen

Module 1: Overview of soil fertility, plant nutrition, and nutrient management. To view the chapter for this topic click here.

Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity

Membrane and Soluble Proteins

VITAPRO. Detoxification properties of Apple pectin formulation, PROPECTIN. CENTRE D ETUDE ET DE VALORISATION DES ALGUES FINAL REPORT.

EURL-SRM - Analytical Observations Report

MD1-46 is presented as 96 x 10 ml conditions.

Chapter 17 Acids and Bases (same as Exam 2 Worksheet Answers)

RUBIC Additive Screen MD1-97 For stable, happy proteins From purification all the way through to characterization by NMR, SAXS or Crystallography.

User Guide HR2-451 (pg 1)

BIOLOGY 101. CHAPTER 7: Membrane Structure and Function: Life at the Edge

Monensin and Extruded Urea-Grain for Range Beef Cows

PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon

FDA Dietary Supplement cgmp

METHOD 8032 ACRYLAMIDE BY GAS CHROMATOGRAPHY

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

How to Get Set Up and Running with NDepend

Action plan: serialisation of Nordic packages focus on Product Codes

Solaire Medical Electronic Lock Software


Pain relief after surgery

MD1-76. Power Combo Value Pack (MD1-46 & MD1-59)

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

Sugar Rush: The Science of Sweet

Completing the NPA online Patient Safety Incident Report form: 2016

Food information to consumers - Commission proposal - COM (2008) 40 final 2008/0028 (COD) The European Heart Network s position in a nutshell

MD1-46 is presented as 96 x 10 ml conditions.

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

The Mental Capacity Act 2005; a short guide for the carers and relatives of those who may need support. Ian Burgess MCA Lead 13 February 2017

FUNCTIONAL MOVEMENT SYSTEMS SCREEN FINDINGS REPORT

The Cannabis Act and Regulations

PILI Lifestyle Program Facilitator s Guide

MGPR Training Courses Guide

Manufacturer of High Purity Chemicals PRODUCT LIST

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

1100 Marie Mount Hall College Park, Maryland Tel: (301) Fax: (301)

The easy way to smart lighting

Understanding Blood Counts

Percutaneous Nephrolithotomy (PCNL)

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Health Consumers Queensland submission

Cancer Association of South Africa (CANSA)

SESSION HANDOUTS ANXIETY SYMPTOMS INTERVENTION. Assertiveness Checklist and Stepladders Fighting Fear by Facing Fear Form SESSION

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

BRCA1 and BRCA2 Mutations

TABLE OF CONTENTS Glossary of terms Code Pad Diagram 3. Understanding the Code Pad lights.4.

Humanities and Social Sciences Division. o Work Experience, General. o Open Entry/Exit. Distance (Hybrid Online) for online supported courses

Lower Extremity Amputation (LEA) Considerations / Issues

Crystal Screens. JBScreen Family JBScreen Formulations. Crystallography

WALNUT KERNEL-HALVES (light color)

Glaucoma Interviews: Due Tuesday, May 22 nd

Osteoporosis Fast Facts

Technology to overcome challanges

ABIOpure TM Total RNA (version 2.0)

OHlympia: becoming the PRODIGY. A Special Thanks to Cary K for giving me the opportunity to do this!

Designing successful membrane protein crystallisation screens: how we designed MemGold. Simon Newstead

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium

Call for evidence on the use of skin sensitisers, skin irritants and corrosive substances in textile and leather articles, hides and furs

Finding the right 90 people in 90 days and what to do with them:

Initial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty.

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets

Frequently Asked Questions: IS RT-Q-PCR Testing

The Cell Cycle & Cellular Division

Test 3 Study Guide: Photosynthesis, Respiration, and the Cell Membrane

INTRODUCTION TO THE CIRCULATORY SYSTEM

PROTOCOL. SOD2 Protein Quantity Microplate Assay Kit. MS746 Rev.0 DESCRIPTION INTRODUCTION

Dosage Administration

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

Effects of Lyophilization on the Catalytic Properties of Extracellular Fructosyltransferase from Rhodotorula sp. LEB-V10

OEE Studio Release Note

Mitosis and Meiosis Lecture Notes

Ontario s Approach to Federal Cannabis Legalization

Instruction Manual IC ACCESS CONTROL

( ) ( ) + ( ) ( ) ( ) + ( )

REGISTERED REPORTS AUTHOR AND REVIEWER GUIDELINES

Corporate Governance Code for Funds: What Will it Mean?

CONSUMER MEDICINE INFORMATION

Transcription:

PACT premier TM HT-96 MD1-36 PACT premier is a ph, Anin, Catin crystallizatin trial devised t test ph within a PEG/In screen. MD1-36 cntains 96 x 1 ml reagents in a deep-well blck. Features f PACT premier A mdern, cmprehensive PEG/in screen. This 96-well screen is really 3 screens in ne: 24-well ph/peg screen 24-well catin/peg screen 48-well anin/peg screen Ratinale fr a new PEG/In screen The first step in crystallizatin is ften t reach fr a cmmercially available sparse matrix kit, and hpe that ne f the cnditins prduces smething that lks harvestable, r ptimizable. If n bvius leads cme ut f the screen, it is hard t learn anything frm the negative (precipitate and clear) results. Traditinal PEG/In screens prvide a lgical test f seven catins and eleven anins using PEG 3350 as the precipitatin agent. Hwever, the user has n cntrl ver ph and hence cannt determine the effect f ne catin r anin ver anther. Fr this reasn the PEG/ION/pH (PACT) screen has been develped t systematically test the effect f ph, anins and catins, using PEG as the precipitant. This screen has been implemented very successfully at the Netherlands Cancer Institute (NKI), and at the Oxfrd Prtein Prductin Facility (OPPF). PACT premier ph/peg screen This cnsists f fur brad range buffer systems (1) versus PEG 1500. These buffers allw ne t scan the ph range frm 4 t 9, withut changing the chemistry f the system, s effectively islating the effect f ph frm the effect f the buffer that causes the change in ph. There are a few screens that try t test crystallizatin space in a mre ratinal manner fr example, the Clear Strategy Screen and The Slubility Tl Kit. Prtein crystals grwn successfully with PACT premier. 1

PACT premier Catin/PEG screen This is made up f six catins (all with chlride cunter ins) that are cmbined with PEG 6000 at fur different phs: Acetate ph 5, MES ph 6, HEPES ph 7 and Tris ph 8. The catins tested are Na +, NH 4 +, Li +, Mg 2+, Ca 2+ and Zn 2+. The zinc in is tested at lwer cncentratin than the ther catins in the screen (0.01 M vs. 0.2 M) Anin/PEG screen This is made up f 12 anins, with either sdium r ptassium cunter ins, which are tested at 0.2 M against PEG 3350. The anins include fluride, brmine, idide, thicyanate, nitrate, frmate, acetate, sulfate, tartrate, phsphate, citrate and malnate. The phsphate slutin is tested at a cncentratin f 0.02 M. Chlride is nt included here as it is the cunter in in the catin screen. Three sets f reagents are tested at ph 6.5, 7.5, and 8.5 with the Bis-Tris-Prpane buffer system whilst ne set f reagents is tested withut buffering. Frmulatin Ntes PACT premier reagents are frmulated using ultrapure water (>18.0 MΩ) and are sterile-filtered using 0.22 µm filters. N preservatives are added. Final ph may vary frm that specified n the datasheet. Mlecular Dimensins will be happy t discuss the precise frmulatin f individual reagents. Individual reagents and stck slutins fr ptimizatin are available frm Mlecular Dimensins. Enquiries regarding PACT-premier frmulatin, interpretatin f results r ptimizatin strategies are welcme. Please e-mail, fax r phne yur query t Mlecular Dimensins. Cntact and prduct details can be fund at www.mleculardimensins.cm References: (1)Newman et al (2005). Twards ratinalizatin f crystallizatin screening fr small- t medium-sized academic labratries: the PACT/JCSG+ strategy. Acta Cryst. D61, 1426-1431. PACT premier- when used tgether with JCSG plus as a primary screening strategy is an extremely pwerful and successful cmbinatin, (i.e. a cmbinatin f a mdern sparse matrix apprach and an infrmatin yielding systematic trial). 2

PACT premier HT-96 Cnditins A1 D12 MD1-36 Well # Cnc. Salt Cnc. Buffer ph Cnc. Precipitant A1 0.1 M SPG 4.0 25 % w/v PEG 1500 A2 0.1 M SPG 5.0 25 % w/v PEG 1500 A3 0.1 M SPG 6.0 25 % w/v PEG 1500 A4 0.1 M SPG 7.0 25 % w/v PEG 1500 A5 0.1 M SPG 8.0 25 % w/v PEG 1500 A6 0.1 M SPG 9.0 25 % w/v PEG 1500 A7 0.2 M Sdium chlride 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 A8 0.2 M Ammnium chlride 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 A9 0.2 M Lithium chlride 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 A10 0.2 M Magnesium chlride hexahydrate 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 A11 0.2 M Calcium chlride dihydrate 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 A12 0.01 M Zinc chlride 0.1 M Sdium acetate 5.0 20 % w/v PEG 6000 B1 0.1 M MIB 4.0 25 % w/v PEG 1500 B2 0.1 M MIB 5.0 25 % w/v PEG 1500 B3 0.1 M MIB 6.0 25 % w/v PEG 1500 B4 0.1 M MIB 7.0 25 % w/v PEG 1500 B5 0.1 M MIB 8.0 25 % w/v PEG 1500 B6 0.1 M MIB 9.0 25 % w/v PEG 1500 B7 0.2 M Sdium chlride 0.1 M MES 6.0 20 % w/v PEG 6000 B8 0.2 M Ammnium chlride 0.1 M MES 6.0 20 % w/v PEG 6000 B9 0.2 M Lithium chlride 0.1 M MES 6.0 20 % w/v PEG 6000 B10 0.2 M Magnesium chlride hexahydrate 0.1 M MES 6.0 20 % w/v PEG 6000 B11 0.2 M Calcium chlride dihydrate 0.1 M MES 6.0 20 % w/v PEG 6000 B12 0.01 M Zinc chlride 0.1 M MES 6.0 20 % w/v PEG 6000 C1 0.1 M PCTP 4.0 25 % w/v PEG 1500 C2 0.1 M PCTP 5.0 25 % w/v PEG 1500 C3 0.1 M PCTP 6.0 25 % w/v PEG 1500 C4 0.1 M PCTP 7.0 25 % w/v PEG 1500 C5 0.1 M PCTP 8.0 25 % w/v PEG 1500 C6 0.1 M PCTP 9.0 25 % w/v PEG 1500 C7 0.2 M Sdium chlride 0.1 M HEPES 7.0 20 % w/v PEG 6000 C8 0.2 M Ammnium chlride 0.1 M HEPES 7.0 20 % w/v PEG 6000 C9 0.2 M Lithium chlride 0.1 M HEPES 7.0 20 % w/v PEG 6000 C10 0.2 M Magnesium chlride hexahydrate 0.1 M HEPES 7.0 20 % w/v PEG 6000 C11 0.2 M Calcium chlride hexahydrate 0.1 M HEPES 7.0 20 % w/v PEG 6000 C12 0.01 M Zinc chlride 0.1 M HEPES 7.0 20 % w/v PEG 6000 D1 0.1 M MMT 4.0 25 % w/v PEG 1500 D2 0.1 M MMT 5.0 25 % w/v PEG 1500 D3 0.1 M MMT 6.0 25 % w/v PEG 1500 D4 0.1 M MMT 7.0 25 % w/v PEG 1500 D5 0.1 M MMT 8.0 25 % w/v PEG 1500 D6 0.1 M MMT 9.0 25 % w/v PEG 1500 D7 0.2 M Sdium chlride 0.1 M Tris 8.0 20 % w/v PEG 6000 D8 0.2 M Ammnium chlride 0.1 M Tris 8.0 20 % w/v PEG 6000 D9 0.2 M Lithium chlride 0.1 M Tris 8.0 20 % w/v PEG 6000 D10 0.2 M Magnesium chlride hexahydrate 0.1 M Tris 8.0 20 % w/v PEG 6000 D11 0.2 M Calcium chlride dihydrate 0.1 M Tris 8.0 20 % w/v PEG 6000 D12 0.002 M Zinc chlride 0.1 M Tris 8.0 20 % w/v PEG 6000 3

PACT premier HT-96 Cnditins E1 H12 MD1-36 Well # Cnc. Salt Cnc. Buffer ph Cnc. Precipitant E1 0.2 M Sdium fluride 20 % w/v PEG 3350 E2 0.2 M Sdium brmide 20 % w/v PEG 3350 E3 0.2 M Sdium idide 20 % w/v PEG 3350 E4 0.2 M Ptassium thicyanate 20 % w/v PEG 3350 E5 0.2 M Sdium nitrate 20 % w/v PEG 3350 E6 0.2 M Sdium frmate 20 % w/v PEG 3350 E7 0.2 M Sdium acetate trihydrate 20 % w/v PEG 3350 E8 0.2 M Sdium sulfate 20 % w/v PEG 3350 E9 0.2 M Ptassium sdium tartrate tetrahydrate 20 % w/v PEG 3350 E10 0.02 M Sdium/ptassium phsphate 20 % w/v PEG 3350 E11 0.2 M Sdium citrate tribasic dihydrate 20 % w/v PEG 3350 E12 0.2 M Sdium malnate dibasic mnhydrate 20 % w/v PEG 3350 F1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F3 0.2 M Sdium idide 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F10 0.02 M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F11 0.2 M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 F12 0.2 M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane 6.5 20 % w/v PEG 3350 G1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G3 0.2 M Sdium idide 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G10 0.02 M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G11 0.2 M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 G12 0.2 M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane 7.5 20 % w/v PEG 3350 H1 0.2 M Sdium fluride 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H2 0.2 M Sdium brmide 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H3 0.2 M Sdium idide 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H4 0.2 M Ptassium thicyanate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H5 0.2 M Sdium nitrate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H6 0.2 M Sdium frmate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H7 0.2 M Sdium acetate trihydrate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H8 0.2 M Sdium sulfate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H9 0.2 M Ptassium sdium tartrate tetrahydrate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H10 0.02 M Sdium/ptassium phsphate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H11 0.2 M Sdium citrate tribasic dihydrate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 H12 0.2 M Sdium malnate dibasic mnhydrate 0.1 M Bis-Tris prpane 8.5 20 % w/v PEG 3350 4

Abbreviatins: HEPES; N-(2-hydrxyethyl)-piperazine-N'-2-ethanesulfnic acid, MES; 2-(N-mrphlin)ethanesulfnic acid, PEG; Plyethylene glycl, Tris; 2-Amin-2-(hydrxymethyl)prpane-1,3-dil, SPG buffer; Succinic Acid, Phsphate, Glycine, MIB buffer; Malnic acid, Imidazle, Bric acid, PCTP buffer; Prpinic acid, Cacdylate, Bis-tris prpane, MMT buffer; Malic acid, MES, Tris. Manufacturer s safety data sheets are available frm ur website r by scanning the QR cde here: Ordering details: Catalgue Descriptin Catalgue Cde PACT premier (96 x 10 ml kit) MD1-29 PACT premier HT-96 (96 x 1 ml) MD1-36 PACT premier Ec Screen (96 x 10 ml kit) MD1-29-ECO PACT premier HT-96 Ec Screen (96 x 1 ml) MD1-36-ECO Green Screens PACT premier Green Screens (96 x 10 ml kit) MD1-55 PACT premier HT-96 Green Screens (96 x 1 ml) MD1-52 Single Reagents PACT premier (100 ml) MDSR-29 - tube number PACT premier HT-96 (100 ml) MDSR-36 - well number PACT premier Green screen (100 ml) MDSR-55 - tube number PACT premier Green screen HT-96 (100 ml) MDSR-52 - well number Fr PACT premier stck reagents visit ur Optimizatin page n ur website. 5